Roux-en-Y (RNY) gastric bypass is a type of weight-loss surgery in which the stomach is divided into a small upper pouch and a larger lower "remnant" portion. The small intestine is rearranged to connect to both. This reduces the stomach's capacity and alters how the body absorbs calories and nutrients, making it one of the most effective bariatric surgeries for long-term weight loss. Patients can expect significant weight loss, but the procedure is more complex than other forms of bariatric surgery, requiring... +More

The Roux-en-Y gastric bypass is a common bariatric surgery where the stomach is divided into a small upper pouch and a larger lower portion. The small intestine is then rearranged to connect with the new stomach pouch. This procedure reduces food intake and limits calorie absorption, making it highly effective for weight loss.

A mini gastric sleeve refers to a less invasive version of the standard sleeve gastrectomy. It’s a simpler procedure that results in a smaller stomach size and helps with long-term weight loss. While not as widely performed, it is an option for those seeking weight-loss surgery with fewer complications.

Feeling sick in your stomach can indicate nausea, indigestion, or an underlying condition such as gastritis, food intolerance, or stress. If persistent, it’s essential to consult a healthcare provider for proper diagnosis and treatment.

Weight loss tablets are medications designed to help individuals lose weight by suppressing appetite or blocking fat absorption. Common examples include Orlistat, which reduces fat absorption, and phentermine, which is an appetite suppressant. These medications are typically prescribed to individuals with a BMI over 30 or those with obesity-related conditions.

A sleeve diet plan involves gradual dietary progression after surgery, focusing on protein-rich foods, minimal carbohydrates, and small portion sizes. Long-term, patients must continue eating nutrient-dense, low-calorie meals to maintain weight loss. Key components include lean meats, vegetables, whole grains, and avoiding sugary and fatty foods.

The cost of Roux-en-Y (RNY) gastric bypass surgery varies widely depending on the country, hospital, and insurance coverage. In the U.S., it typically ranges between $20,000 and $30,000. In the UK, the procedure may be covered by the NHS if the patient meets specific criteria, or it can be done privately for £8,000 to £15,000.

Gastritis treatment focuses on reducing inflammation in the stomach lining. This may involve antacids, proton pump inhibitors, or antibiotics if caused by H. pylori infection. Lifestyle changes, such as avoiding spicy foods, alcohol, and NSAIDs, can also help manage symptoms.

Roux-en-Y gastric bypass is one of the most common bariatric surgeries, combining restrictive and malabsorptive techniques. It helps patients lose weight by creating a small stomach pouch and bypassing part of the small intestine, reducing calorie absorption. It’s highly effective but requires lifelong dietary changes and nutritional supplementation.

Wegovy (semaglutide) is a medication that helps with weight loss by mimicking a hormone that regulates appetite. It is prescribed to individuals with obesity or those with weight-related health problems. In the UK, Wegovy has been approved for NHS use for patients who meet certain criteria, providing a non-surgical option for those seeking medical weight-loss assistance.

Gastritis can sometimes cause referred pain that radiates to the back, although this is not a common symptom. If a patient experiences back pain along with gastritis symptoms like nausea, bloating, or indigestion, it could indicate a more severe condition or complications such as ulcers.

Semaglutide is a weight-loss medication that mimics a hormone regulating appetite and food intake. In the UK, it is marketed under the brand names Ozempic (for diabetes) and Wegovy (for obesity). It is prescribed to individuals struggling with weight management, often in conjunction with diet and exercise.

The Orbera gastric balloon is a non-surgical, temporary weight-loss device placed in the stomach to reduce food intake. The balloon is inflated and left in place for six months. During that time, patients follow a strict diet and exercise regimen to lose weight. It’s a popular choice for patients who want to avoid invasive surgery.

A sick tummy feeling refers to nausea, which can have many causes, including gastritis, food poisoning, or acid reflux. Depending on the severity, nausea may be treated with antacids, dietary adjustments, or medications like anti-nausea drugs.

Wegovy is available through the NHS for patients meeting specific criteria. To qualify, individuals generally need to have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as diabetes or hypertension. Wegovy is a relatively new option and is prescribed under careful medical supervision.